UltraSPECT

Biotechnology, Health Care, Medical Device, Pharmaceutical
Founded in 1999-01-01
Haifa, Hefa, Israel
http://www.ultraspect.com
For Profit

About UltraSPECT

UltraSPECT is a leading supplier of Software Products for the Nuclear Medicine imaging practices providing innovative and cost-effective solutions for improved clinical outcomes and patient safety delivered by Gamma Cameras and PET. Based on proprietary, innovative reconstruction algorithms technology, Wide-Beam Reconstruction (WBR™), the Company's imaging solutions shorten acquisition times, lower dose requirements, and increase image resolution. Xpress.Cardiac™ enables rest/stress studies to be acquired using either half the radiopharmaceutical dose or half the scan time, depending on the patient and the physician’s preference. Xpress3.Cardiac™ offers simultaneous reduced-dose and reduced-time imaging, facilitating increased patient safety and comfort. Image quality is enhanced in all applications.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 15 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: None USD
  • Last Funding: None (Venture - Series Unknown)
  • Funding Status:

Technology Stack

UltraSPECT actively uses 15 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Medical Device, Pharmaceutical

Headquarters: Haifa, Hefa, Israel